SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity
Gunther Boysen, Johann S. de Bono(Royal Marsden NHS Foundation Trust), George Seed(Institute of Cancer Research), Jane Goodall, Pasquale Rescigno(Royal Marsden NHS Foundation Trust), Wei Yuan(Chinese Academy of Medical Sciences & Peking Union Medical College), Sara Aziz(Imperial College London), Theresa Y. MacDonald(NewYork–Presbyterian Hospital), Raquel Pérez-López(Royal Marsden NHS Foundation Trust), Veronica Gil(Cancer Research UK), David Dolling(Institute of Cancer Research), Christopher E. Barbieri(Cornell University), Matthew Clarke(Institute of Cancer Research), Mark A. Rubin(University of Bern), Joaquı́n Mateo(Hebron University), Deirdre Moloney(Royal Marsden NHS Foundation Trust), Mateus Crespo(Institute of Cancer Research), Flavia M. de Oliveira(Institute of Cancer Research), Rossitza Christova(Institute of Cancer Research), Nina Tunariu(Leicester Royal Infirmary), Susana Miranda(Royal Marsden NHS Foundation Trust), Ruth Riisnaes(Institute of Cancer Research), Mark Atkin(Institute of Cancer Research), Adam Sharp(Institute of Cancer Research), Ana Ferreira(Institute of Cancer Research), Daniel Nava Rodrigues(Royal Marsden NHS Foundation Trust), Zafeiris Zafeiriou(Royal Marsden NHS Foundation Trust), Suzanne Carreira(Institute of Cancer Research), Diletta Bianchini(Royal Marsden NHS Foundation Trust), Inês Figueiredo(Institute of Cancer Research), Cláudia Bertan(Institute of Cancer Research), Joanne Hunt(Royal Marsden NHS Foundation Trust), Semini Sumanasuriya(Institute of Cancer Research)
Cited by 140
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k